By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Nvidia Earnings Ahead Please click here for a chart of Nvidia stock (NVDA). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of NVDA stock
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Hotter Inflation Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows a slight pullback on
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Small Caps Please click here for a chart of small cap Russell 2000 ETF (IWM). Note the following: The chart shows the 2021 high in small caps. The chart shows the high in
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term. DraftKings (DKNG) is long from $17.74. It
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Revised CPI Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the revised CPI data
By Nigam Arora & Dr. Natasha Arora Here are the key points investors need to know about opportunities in infrastructure: Two of the Infrastructure Model Portfolio companies have already been bought out, producing great gains. USCR is already closed, and members received $74 per share in cash in the buyout. X has a $55
By Nigam Arora & Dr. Natasha Arora 39.5% Profit In One Day The Arora Report gave a signal to buy biotech MorphoSys AG (MOR). The signal stated that MorphoSys was likely to be bought out and result in hefty gains for investors. Only a day later, a major, multinational, biopharma company Novartis
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Sentiment Lifting Please click here for a chart of Hong Kong ETF (FXI). Note the following: Sentiment is lifting in stock markets all across the globe as Chinese stocks fly. The chart shows
By Nigam Arora & Dr. Natasha Arora India continues to be the best large emerging economy story for long term investors. The Arora Report has been covering India for 16 years in ZYX Emerging. Budget For the Indian economy and the stock market, the government budget is always a big driver.